HTLV-1 Tax Specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications by Leal, Fabio E et al.
MEETING ABSTRACT Open Access
HTLV-1 Tax Specific CD8+ T cells express low
levels of Tim-3 in HTLV-1 infection: implications
for progression to neurological complications
Fabio E Leal
1,2*, Lishomwa C Ndhlovu
3, Aaron M Hasenkrug
3, Aashish R Jha
3, Karina I Carvalho
1,
Ijeoma G Eccles-James
3, Fernanda R Bruno
1, Raphaella G Vieira
3, Vanessa A York
3, R Brad Jones
4, Yuetsu Tanaka
5,
Walter K Neto
6, Sabri S Sanabani
6, Mario A Ostrowski
4, Aluisio C Segurado
2, Douglas F Nixon
3, Esper G Kallas
1,2
From 15th International Conference on Human Retroviruses: HTLV and Related Viruses
Leuven and Gembloux, Belgium. 5-8 June 2011
Background
Most patients with HTLV-1 infection are asymptomatic,
however 3% of individuals develop a progressive neuro-
logical disorder, HTLV-1 associated myelopathy/tropical
spastic paraparesis (HAM/TSP). Factors leading to this
complication are not well defined, but are associated
with high levels of pro-virus and cytolytic T cells. Dur-
ing chronic viral infections, virus-specific CD8+ T cells
undergo altered patterns of differentiation and can
become restrained from effector activity. We hypothe-
sized that suppression of immune receptors T cell
immunoglobulin and mucin domain-containing protein
3 (Tim-3) and PD-1 would result in partial reversal of a
T cell restraint profile. In turn this increased cytolytic
activity may mediate neuro-immunopathology of HAM/
TSP.
Methods
We investigated the expression of Tim-3 and PD-1 on T
cells in 22 serially recruited HTLV-1 asymptomatic and
HAM/TSP patients and 7 HTLV-1-seronegative
matched controls, their distribution on HTLV-1-specific
T cells and the relationship with T cell function.
Results
Using flow cytometry, we found that patients with
HAM/TSP had significantly lower levels of Tim-3+ PD-
1- expressing CD8+ (p=0.002) and CD4+ (p=0.004) T
cells compared to healthy uninfected controls. HTLV-1
Tax11-19, HLA-A*02 restricted CD8+ T cells among
HAM/TSP individuals expressed markedly lower levels
of Tim-3. Furthermore, we found that the frequency of
Tim-3 expressing Tax11-19 specific CD8+ T cells inver-
sely correlated with the number of IFN-g secreting cells
in response to the Tax Tax11-19 peptide.
Conclusions
We propose that this low expression of Tim-3 on
HTLV-1 Tax-specific T cells may lead to persistent and
deleterious effector T cell pool, resulting in more
inflammation and disease progression.
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